13th Annual Fall Midwest Thoracic and GI Oncology Conference

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

13th Annual Fall Midwest Thoracic and GI Oncology Conference

GI
Lung
Events

Playback speed

10 seconds

Immunotherapy for Metastatic NSCLC - Immunity Mechanisms, Anti-PD1/PDL-1 Therapy New Standard of Care, Mechanism of Immune Checkpoint Blockade, Immuno + Chemo & Future Directions

By 13th Annual Fall Midwest Thoracic and GI Oncology Conference FEATURING Manish R. Patel

148 views

December 13, 2018

Comments 1

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Lung

Lung Cancer in Former Smokers

13th Annual Fall Midwest Thoracic and GI Oncology Conference

M. Kessinger

292 views

Immunotherapy for Metastatic NSCLC - Immunity Mechanisms, Anti-PD1/P…

13th Annual Fall Midwest Thoracic and GI Oncology Conference

M. Patel

148 views

Current Issues and Potential Future Applications of Radiation Therap…

13th Annual Fall Midwest Thoracic and GI Oncology Conference

C. Zhang

437 views

Immunomodulation from Local Radio Therapy in Lung Cancer

13th Annual Fall Midwest Thoracic and GI Oncology Conference

C. Zhang

97 views

How to Manage Relapsed SCLC & data from ImPower: Result of Atezolizu…

13th Annual Fall Midwest Thoracic and GI Oncology Conference

A. Ganti

490 views

NSCLC Practical Tips in Management of Immunotherapy Side Effects on …

13th Annual Fall Midwest Thoracic and GI Oncology Conference

J. Hurley

425 views

Management of Ground-Glass Opacity Lesions in Lung Cancer

13th Annual Fall Midwest Thoracic and GI Oncology Conference

K. Trujillo

123 views

Targeting EGFR in NSCLC: Osimertinib, What is the Best TKI Upfront a…

13th Annual Fall Midwest Thoracic and GI Oncology Conference

V. Ernani

554 views

Targeting ALK in NSCLC: Alectinib 1st Line Treatment Choice, New Pro…

13th Annual Fall Midwest Thoracic and GI Oncology Conference

V. Ernani

362 views

NSCLC Updated Molecular Testing Guidelines for 2018

13th Annual Fall Midwest Thoracic and GI Oncology Conference

J. Cox

134 views

Molecular Testing Genes in NSCLC, Emerging Markers and Next Generati…

13th Annual Fall Midwest Thoracic and GI Oncology Conference

J. Cox

351 views

Immunotherapy in Early Stage NSCLC and PACIFIC Trial of Durvalumab i…

13th Annual Fall Midwest Thoracic and GI Oncology Conference

A. Marr

512 views

Is There Any Role of Immunotherapy in NSCLC Stage 1 & Stage 2?

13th Annual Fall Midwest Thoracic and GI Oncology Conference

A. Marr

477 views

Brief History of Robotics in Surgery

13th Annual Fall Midwest Thoracic and GI Oncology Conference

D. Berkheim

77 views

Robotic Assisted Thymectomy

13th Annual Fall Midwest Thoracic and GI Oncology Conference

D. Berkheim

286 views

Robotic Assisted Lobectomy

13th Annual Fall Midwest Thoracic and GI Oncology Conference

D. Berkheim

284 views

Radiology - What Does Ground Glass/Sub-Solid Mean?

13th Annual Fall Midwest Thoracic and GI Oncology Conference

M. DeVries

29 views

What Processes Can Use Ground Glass and How That Relates to Small Ad…

13th Annual Fall Midwest Thoracic and GI Oncology Conference

W. West

42 views

Current Recommendations for Follow Up/Management of Sub-Solid Nodules

13th Annual Fall Midwest Thoracic and GI Oncology Conference

M. DeVries

30 views

Ground Glass/Sub-Solid Nodules Q&A

13th Annual Fall Midwest Thoracic and GI Oncology Conference

W. West, M. DeVries

543 views